Tenth Anniversary of Needlestick Safety & Prevention Act: Charting a Future Path

描述(由申请人提供)：美国针灸安全和预防法案十周年：绘制进展，绘制未来道路当针灸安全和预防法案(NSPA)于2000年11月6日签署成为法律时，美国(美国)成为世界上第一个要求使用安全设计的锐利医疗设备的国家，旨在保护医护人员免受锐伤和血源性疾病的传播。十年后，是时候评估NSPA的影响，确定Sharps安全技术方面的剩余差距，并制定未来消除针头作为美国医疗机构职业风险的道路--2001年被疾病控制和预防中心确定为七个“医疗安全挑战”之一。为了实现这一目标，有必要继续保持警惕，以确保有效的安全技术在全国医院和门诊设置中可用并持续使用。弗吉尼亚大学国际医疗工作者安全中心提议在2010年召开一次会议，探讨这些重要问题。来自不同部门的利益攸关方--医疗保健、学术界、政府和工业界--将被邀请积极参与制定下一个十年的议程，该议程的范围既包括国家范围，也包括国际范围。NSPA的影响远远超出了美国：它已经成为其他国家加强安全立法的典范，欧盟也准备通过一项同等的标准，大大加快向安全技术的过渡。在过去的15年里，美国医疗器械公司率先开发和营销安全工程医疗器械，推动了世界各国对此类产品的需求。这次会议将提供一个机会，讨论全球安全设备市场的未来，以及需要克服的障碍，以便将这种可能挽救生命的技术带给最贫穷国家的卫生工作者，他们最有可能受到职业感染。这次会议的成果将包括一篇回顾NSPA的影响并为进一步降低美国针刺伤害率提出建议的科学论文；一份白皮书，其中包含将锐伤技术的好处扩大到世界经济困难地区的卫生工作者的战略计划；以及一个会议网站，其中包括演讲者演讲和关键建议的链接。 与公共卫生相关：会议将探讨过去十年在解决医护人员的一项严重职业风险方面取得的成功和面临的挑战：针刺伤和职业性血液暴露。更具体地说，会议将审查美国的监管和立法程序如何成功地针对一个重大的公共卫生问题，以及由此产生的立法在美国和世界各国的影响。

DESCRIPTION (provided by applicant): Tenth Anniversary of the U.S. Needlestick Safety and Prevention Act: Mapping Progress, Charting a Future Path When the Needlestick Safety and Prevention Act (NSPA) was signed into law on November 6, 2000, the United States (U.S.) became the first country in the world to require the use of safety-engineered sharp medical devices designed to protect healthcare workers from sharps injuries and bloodborne disease transmission. Ten years later, it is time to assess the impact of the NSPA, identify remaining gaps in sharps safety technology, and chart a future path towards eliminating needlesticks as an occupational risk in U.S. healthcare facilities-identified as one of seven "healthcare safety challenges" by the Centers for Disease Control and Prevention in 2001. In order to meet that goal, continued vigilance is necessary to ensure that effective safety technology is both available and consistently used in hospitals and outpatient settings nationwide. The International Healthcare Worker Safety Center at the University of Virginia proposes to hold a conference in 2010 to explore these important issues. Stakeholders from a variety of sectors-healthcare, academia, government, and industry-will be invited to actively participate in shaping an agenda for the next decade that is both national and international in scope. The NSPA has had an impact far beyond the U.S.: it has become a model for sharps safety legislation in other countries, and the European Union is poised to pass an equivalent standard that will greatly accelerate transition to safety technology there. Over the last decade and a half, U.S. medical device companies pioneered the development and marketing of safety-engineered medical devices, driving demand for such products in countries worldwide. The conference will provide an opportunity to discuss the future of the global safety device market, and the hurdles that need to be overcome to bring this potentially life-saving technology to health workers in the poorest countries, who are most at risk of occupational infection. Deliverables from the conference will include a scientific paper reviewing the impact of the NSPA and offering recommendations for achieving further reductions in U.S. needlestick injury rates; a white paper with a strategic plan for extending the benefits of sharps injury technology to health workers in economically challenged regions of the world; and a conference website that includes links to speaker presentations and key recommendations. PUBLIC HEALTH RELEVANCE: The conference will explore successes and challenges over the last decade in addressing a serious occupational risk for healthcare workers: needlestick injuries and occupational blood exposures. More specifically, the conference will examine how the U.S. regulatory and legislative process was successfully used to target a significant public health issue, and the impact of the resulting legislation both in the U.S. and in countries worldwide.